Remdesivir for the treatment of COVID-19
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, Agata Mikolajewska, Volker Thieme, Vanessa Piechotta, Maria-Inti Metzendorf, Miriam Stegemann, Carina Benstoem, Falk Fichtner
Cochrane Database of Systematic Reviews, doi:10.1002/14651858.cd014962
Trusted evidence. Informed decisions. Better health.
Cochrane
Library Trusted evidence. Informed decisions. Better health.
Cochrane Database of Systematic Reviews Did patients get better with remdesivir? • Remdesivir may have little or no e ect on the length of time patients spent on invasive mechanical ventilation (2 studies, 1298 people). • We do not know whether remdesivir increases or decreases time on supplemental oxygen (3 studies, 1691 people).
Did patients get worse with remdesivir? • We do not know whether patients are more or less likely to need any mechanical ventilation (invasive or non-invasive) with remdesivir (3 studies, 6696 people). • Patients may be less likely to need invasive mechanical ventilation (2 studies, 1159 people). • We do not know whether patients are more or less likely to need non-invasive mechanical ventilation (1 study, 573 people). • We do not know whether patients are more or less likely to need oxygen by mask or nasal prongs (1 study, 138 people) .
Quality of life • None of the included studies reported quality of life.
Unwanted e ects • We do not know whether remdesivir leads to more or fewer unwanted e ects of any level (3 studies, 1674 people) . • Patients are probably less likely to experience serious unwanted e ects with remdesivir than with placebo or standard care (3 studies, 1674 people) . In 1000 people, 63 fewer would experience a serious unwanted e ect compared to placebo or standard care.
What are the limitations of the evidence? We are moderately confident in the..
References
Ader ; Ader, Er-Smadja, Poissy, Bouscambert-Duchamp, Belhadi et al., Antiviral drugs in hospitalised patients with COVID-19 -the DisCoVeRy trial, CLINICALTRIALS.GOV,
doi:10.1101/2021.01.08.20248149Beigel, Beigel, Tomashek, Dodd, Mehta et al., Remdesivir for the treatment of COVID-19 -final report, New England Journal of Medicine,
doi:10.1056/NEJMoa2007764Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the treatment of COVID-19 -preliminary report, New England Journal of Medicine,
doi:10.1056/NEJMoa2007764Beigel, Tomashek, Dodd, Remdesivir for the treatment of COVID-19 -preliminary report, New England Journal of Medicine,
doi:10.1056/NEJMc2022236Deresinski, Treatment of COVID-19 patients with remdesivir, hydroxychloroquine, lopinavir, or interferon beta-1a
Elliott, Elliot, Chan, Deresinski 2020 {published data only} Deresinski S. Remdesivir and COVID-19
Excel, Microso Corporation ; Moher ; Moher, Liberati, Tetzla, Altman et al., SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology, New England Journal of Medicine,
doi:10.1371/journal.pmed.1000097Eynde, Consortium. Repurposed antiviral drugs for COVID-19 -interim WHO solidarity trial results, New England Journal of Medicine,
doi:10.3390/ph13050098Funk, Pharris, Spiteri, Bundle, Melidou et al., Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021, Eurosurveillance,
doi:10.2807/1560-7917.ES.2021.26.16.2100348Gautret, Million, Jarrot, Jau, Colson et al., Natural history of COVID-19 and therapeutic options, Expert Review of Clinical Immunology,
doi:10.1080/1744666X.2021.1847640Goldberg, Zvi, Sheena, Sofer, Krause et al., A real-life setting evaluation of the e ect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel,
doi:10.1056/NEJMoa2015301]ISRCTN15874265Goldman, Goldman, Lye, Hui, Marks et al., Impact of baseline alanine aminotransferase levels on the safety and e icacy of remdesivir in severe COVID-19 patients
Grubaugh, Hanage, Rasmussen, Higgins, Thompson et al., Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear,
doi:10.1016/j.cell.2020.06.040Hu 2020 Hu, Song, Xu, Chen, Xu, Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China, Science China Life Sciences,
doi:10.1007/s11427-020-1661-4Huang 2020 Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet,
doi:10.1016/S0140-6736(20)30183-5Kaka 2021 Kaka, Macdonnald, Greer, Vela, Duan-Porter et al., Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians Practice Points, Annals of Internal Medicine,
doi:10.7326/L21-0130Karagiannidis, Mostert, Hentschker, Voshaar, Malzahn et al., Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study, Cochrane Database of Systematic Reviews,
doi:10.1016/S2213-2600(20)30316-7Ko, Remdesivir reduces time to recovery in adults hospitalised with COVID-19: a meaningful step in therapeutic discovery, Journal of Clinical Outcomes Management,
doi:10.1056/NEJMoa2007764]NCT04280705Lai 2021 Lai, Chen, Wang, Chen, Wang et al., Clinical e icacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomised controlled trials, Journal of Antimicrobial Chemotherapy,
doi:10.1093/jac/dkab093Li 2020b Li, Geng, Peng, Meng, Lu et al., Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Journal of Pharmaceutical Analysis,
doi:10.1016/j.jpha.2020.03.001Lo 2017 Lo, Jordan, Arvey, Sudhamsu, Shrivastava-Ranjan et al., GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses, Scientific Reports,
doi:10.1038/srep43395Malaiyan, Arumugam, Mohan, Malin ; Malin, Suárez et al., An update on the origin of SARS-CoV-2: despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues, Clinical Microbiology Reviews,
doi:10.1002/jmv.26261Mcguigan, Hassan-Abdallah, Srinivasan, Wang, Siddiqui et al., Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives, Journal of Medicinal Chemistry,
doi:10.1021/jm060776wMeng ; Meng, Xiong, He, Lin, Hao et al., CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China, Journal of Infection,
doi:10.1016/j.jinf.2020.04.004O N T R I B U T I O N S O F A U T H O R S Ka ; D E C L A R A T I O N S O F I N T E R, CB: methodological expertise and advice, data extraction and assessment, conception, writing and proofreading of the manuscript. FF: clinical expertise and advice, data extraction and assessment, conception, writing and proofreading of the manuscript
Olalla, Remdesivir for the treatment of COVID-19 -preliminary report, New England Journal of Medicine,
doi:10.1056/NEJMc2022236Olsen, Henriksen, Kåsine, Lund-Johansen, Hoel, Evaluation of remdesivir and hydroxychloroquine on viral clearance in COVID-19 patients: results from the NOR-solidarity randomised trial, CLINICALTRIALS.GOV,
doi:10.2139/ssrn.3774182Oran ; Oran, Topol, Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review, Annals of Internal Medicine,
doi:10.7326/M20-3012Paladugu, Donato, Remdesivir improved time to recovery in adults hospitalised with COVID-19 and lower respiratory tract involvement, Annals of Internal Medicine,
doi:10.7326/ACPJ202007210-005Pan 2020 Pan, Liu, Wang, Guo, Hao et al., Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study, Statistics in Medicine,
doi:10.1001/jama.2020.6130Pan, Peto, Karim, Alejandria, Henao-Restrepo et al., Repurposed antiviral drugs for COVID-19 -interim WHO solidarity trial results, CLINICALTRIALS.GOV,
doi:10.1101/2020.10.15.20209817Piechotta, Valk, Chai, Wood, Lamikanra et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area,
doi:10.1371/journal.pone.0243705Schilling, Lehfeld, Schumacher, Ullrich, Diercke et al., Disease severity of the first COVID-19 wave in Germany using reporting data from the national notification system,
doi:10.25646/7170Schwarz, Tober-Lau, Hillus, Helbig, Lippert et al., Comparative therapeutic e icacy of remdesivir and combination lopinavir, ritonavir and interferon beta against MERS-CoV, Science Translational Medicine,
doi:10.3201/eid2708.211145Siegel 2017 Siegel, Hui, Doer Ler, Chun, Zhang, Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the treatment of ebola and emerging viruses, Cochrane Database of Systematic Reviews,
doi:10.1021/acs{ 'indexed': {'date-parts': [[2024, 5, 14]], 'date-time': '2024-05-14T11:51:32Z', 'timestamp': 1715687492399},
'reference-count': 204,
'publisher': 'Wiley',
'issue': '8',
'content-domain': {'domain': ['wiley.com', 'cochranelibrary.com'], 'crossmark-restriction': True},
'DOI': '10.1002/14651858.cd014962',
'type': 'journal-article',
'created': {'date-parts': [[2021, 8, 5]], 'date-time': '2021-08-05T06:46:46Z', 'timestamp': 1628146006000},
'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 64,
'title': 'Remdesivir for the treatment of COVID-19',
'prefix': '10.1002',
'volume': '2021',
'author': [ { 'given': 'Kelly',
'family': 'Ansems',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Intensive Care Medicine; Medical Faculty, RWTH '
'Aachen University; Aachen Germany'}]},
{ 'given': 'Felicitas',
'family': 'Grundeis',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Anaesthesiology and Intensive Care; University of '
'Leipzig Medical Center; Leipzig Germany'}]},
{ 'given': 'Karolina',
'family': 'Dahms',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Intensive Care Medicine; Medical Faculty, RWTH '
'Aachen University; Aachen Germany'}]},
{ 'given': 'Agata',
'family': 'Mikolajewska',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Infectious Diseases and Respiratory Medicine; '
'Charité - Universitätsmedizin Berlin, corporate member of Freie '
'Universität Berlin and Humboldt-Universität zu Berlin; Berlin '
'Germany'}]},
{ 'given': 'Volker',
'family': 'Thieme',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Anaesthesiology and Intensive Care; University of '
'Leipzig Medical Center; Leipzig Germany'}]},
{ 'given': 'Vanessa',
'family': 'Piechotta',
'sequence': 'additional',
'affiliation': [ { 'name': 'Cochrane Haematology, Department I of Internal Medicine, Center '
'for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty '
'of Medicine and University Hospital Cologne, University of '
'Cologne; Cologne Germany'}]},
{ 'given': 'Maria-Inti',
'family': 'Metzendorf',
'sequence': 'additional',
'affiliation': [ { 'name': 'Cochrane Metabolic and Endocrine Disorders Group; Institute of '
'General Practice, Medical Faculty of the '
'Heinrich-Heine-University Düsseldorf; Düsseldorf Germany'}]},
{ 'given': 'Miriam',
'family': 'Stegemann',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Infectious Diseases and Respiratory Medicine; '
'Charité - Universitätsmedizin Berlin, corporate member of Freie '
'Universität Berlin and Humboldt-Universität zu Berlin; Berlin '
'Germany'}]},
{ 'given': 'Carina',
'family': 'Benstoem',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Intensive Care Medicine; Medical Faculty, RWTH '
'Aachen University; Aachen Germany'}]},
{ 'given': 'Falk',
'family': 'Fichtner',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Anaesthesiology and Intensive Care; University of '
'Leipzig Medical Center; Leipzig Germany'}]}],
'member': '311',
'published-online': {'date-parts': [[2021, 8, 5]]},
'reference': [ { 'key': '10.1002/14651858.CD014962-BIB0001|cit1',
'doi-asserted-by': 'publisher',
'first-page': '1813',
'DOI': '10.1056/NEJMoa2007764',
'article-title': 'Remdesivir for the treatment of COVID-19 - final report',
'volume': '383',
'year': '2020',
'journal-title': 'New\xa0England Journal of Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0002|cit2',
'unstructured': 'Beigel JH \xa0Dodd LE Remdesivir for the treatment of COVID-19 - '
'preliminary report New England Journal of Medicine 10.1056/NEJMc2022236 '
'32649078'},
{ 'key': '10.1002/14651858.CD014962-BIB0003|cit3',
'doi-asserted-by': 'publisher',
'first-page': '1813',
'DOI': '10.1056/NEJMoa2007764',
'article-title': 'Remdesivir for the treatment of COVID-19 - preliminary report',
'volume': '383',
'author': 'Beigel',
'year': '2020',
'journal-title': 'New England Journal of Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0004|cit4',
'doi-asserted-by': 'crossref',
'unstructured': 'Epstein M Avoiding the termination of ACTT European Heart Journal 2020 '
'10.1093/eurheartj/ehaa546',
'DOI': '10.1093/eurheartj/ehaa546'},
{ 'key': '10.1002/14651858.CD014962-BIB0005|cit5',
'unstructured': 'A multicenter, adaptive, randomised blinded controlled trial of the '
'safety and efficacy of investigational therapeutics for the treatment of '
'COVID-19 in hospitalised adults - version for European Union/United '
'Kingdom sites '
'www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001052-18-DE'},
{ 'key': '10.1002/14651858.CD014962-BIB0006|cit6',
'unstructured': 'Conflicting results on the efficacy of remdesivir in hospitalised '
'COVID-19 patients:\xa0comment on the adaptive COVID-19 treatment trial '
'European Heart Journal 2020 10.1093/eurheartj/ehaa934'},
{ 'key': '10.1002/14651858.CD014962-BIB0007|cit7',
'unstructured': 'Adaptive COVID-19 treatment trial in the EU & UK '
'www.isrctn.com/ISRCTN13035264'},
{ 'key': '10.1002/14651858.CD014962-BIB0008|cit8',
'unstructured': 'A multicenter, adaptive, randomised blinded controlled trial of the '
'safety and efficacy of investigational therapeutics for the treatment of '
'COVID-19 in hospitalised\xa0adults '
'https://jrct.niph.go.jp/latest-detail/jRCT2031190264'},
{ 'key': '10.1002/14651858.CD014962-BIB0009|cit9',
'doi-asserted-by': 'crossref',
'unstructured': 'Ko F Remdesivir\xa0reduces time to recovery in adults hospitalised\xa0'
'with COVID-19: a\xa0meaningful step in therapeutic discovery Journal of '
'Clinical Outcomes Management 2020 10.1056/NEJMoa2007764',
'DOI': '10.12788/jcom.0010'},
{ 'key': '10.1002/14651858.CD014962-BIB0010|cit10',
'unstructured': 'Adaptive COVID-19 treatment trial (ACTT) '
'clinicaltrials.gov/ct2/show/NCT04280705'},
{ 'key': '10.1002/14651858.CD014962-BIB0011|cit11',
'unstructured': 'Olalla J Remdesivir for the treatment of COVID-19 - preliminary report '
'New England Journal of Medicine 10.1056/NEJMc2022236'},
{ 'key': '10.1002/14651858.CD014962-BIB0012|cit12',
'doi-asserted-by': 'crossref',
'unstructured': 'Remdesivir improved time to recovery in adults hospitalised with '
'COVID-19 and lower respiratory tract involvement Annals of Internal '
'Medicine 2020 173 2 JC4 5 10.7326/ACPJ202007210-005 32687756',
'DOI': '10.7326/ACPJ202007210-005'},
{ 'key': '10.1002/14651858.CD014962-BIB0013|cit13',
'doi-asserted-by': 'publisher',
'first-page': '41',
'DOI': '10.4103/ija.IJA_149_21',
'article-title': 'Clinical outcomes of using remdesivir in patients with moderate to '
'severe COVID-19: a prospective randomised study',
'volume': '65',
'author': 'Mahajan',
'year': '2021',
'journal-title': 'Indian Journal of Anaesthesia'},
{ 'key': '10.1002/14651858.CD014962-BIB0014|cit14',
'unstructured': 'This study will test a drug named remdesivir (GS-5734 TM ) to evaluate '
'the safety and effectiveness of the drug in treating patients with '
'moderate coronavirus disease 2019 (COVID-19) compared to standard of '
'care treatment '
'https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/ES'},
{ 'key': '10.1002/14651858.CD014962-BIB0015|cit15',
'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir '
'(GS-5734™) in participants with moderate coronavirus disease (COVID-19) '
'compared to standard of care treatment '
'clinicaltrials.gov/ct2/show/results/NCT04292730'},
{ 'issue': '11',
'key': '10.1002/14651858.CD014962-BIB0016|cit16',
'doi-asserted-by': 'publisher',
'first-page': '1048',
'DOI': '10.1001/jama.2020.16349',
'article-title': 'Effect of remdesivir vs standard care on clinical status at 11 days in '
'patients with moderate COVID-19: a randomised clinical trial',
'volume': '324',
'author': 'Spinner',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '10.1002/14651858.CD014962-BIB0017|cit17',
'unstructured': 'A trial of remdesivir in adults with severe COVID-19 '
'clinicaltrials.gov/ct2/show/NCT04257656'},
{ 'issue': '10236',
'key': '10.1002/14651858.CD014962-BIB0018|cit18',
'doi-asserted-by': 'publisher',
'first-page': '1569',
'DOI': '10.1016/s0140-6736(20)31022-9',
'article-title': 'Remdesivir in adults with severe COVID-19: a randomised, double-blind, '
'placebo-controlled, multicentre trial',
'volume': '395',
'year': '2020',
'journal-title': 'The Lancet'},
{ 'key': '10.1002/14651858.CD014962-BIB0019|cit19',
'unstructured': 'Wang Y Zhang D Du G Remdesivir in adults with severe COVID-19: a '
'randomised, double-blind, placebo-controlled, multicentre trial Lancet '
'2020 395 10238 1569, poster'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0020|cit20',
'doi-asserted-by': 'publisher',
'first-page': '422',
'DOI': '10.1186/s13063-020-04352-9',
'article-title': 'Evaluation of the efficacy and safety of intravenous remdesivir in '
'adult patients with severe COVID-19: study protocol for a phase 3 '
'randomised, double-blind, placebo-controlled, multicentre trial',
'volume': '21',
'author': 'Wang',
'year': '2020',
'journal-title': 'Trials'},
{ 'key': '10.1002/14651858.CD014962-BIB0021|cit21',
'doi-asserted-by': 'publisher',
'first-page': 'e041437',
'DOI': '10.1136/bmjopen-2020-041437',
'article-title': 'Protocol for the discovery trial: multicentre, adaptive, randomised '
'trial of the safety and efficacy of treatments for COVID-19 in '
'hospitalised adults',
'volume': '10',
'year': '2020',
'journal-title': 'BMJ Open'},
{ 'key': '10.1002/14651858.CD014962-BIB0022|cit22',
'doi-asserted-by': 'publisher',
'DOI': '10.2139/ssrn.3774182',
'article-title': 'Evaluation of remdesivir and hydroxychloroquine on viral clearance in '
'COVID-19 patients: results from the NOR-solidarity randomised trial '
'(preprint)',
'author': 'Barratt-Due',
'year': '2021',
'journal-title': 'SSRN'},
{ 'key': '10.1002/14651858.CD014962-BIB0023|cit23',
'unstructured': 'A clinical trial to study the effects of additional treatments for '
'patients hospitalised and receiving treatment due to COVID -19 '
'www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897'},
{ 'key': '10.1002/14651858.CD014962-BIB0024|cit24',
'unstructured': 'Treatment of COVID-19 patients with remdesivir, hydroxychloroquine, '
'lopinavir, or interferon beta-1a Infectious Disease Alert 2021 40 4'},
{ 'key': '10.1002/14651858.CD014962-BIB0025|cit25',
'unstructured': 'Multi-centre, adaptive, randomised trial of the safety and efficacy of '
'treatments of COVID-19 in hospitalised adults - discovery '
'www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/FR'},
{ 'key': '10.1002/14651858.CD014962-BIB0026|cit26',
'unstructured': 'Safety and efficacy of treatments of COVID-19 in hospitalised adults '
'(discovery) '
'www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/PT'},
{ 'key': '10.1002/14651858.CD014962-BIB0027|cit27',
'unstructured': 'A clinical study to evaluate the efficacy of different anti-viral drugs '
'in SARS-CoV-2 infected patients (COVID-19) '
'https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000982-18/NO'},
{ 'key': '10.1002/14651858.CD014962-BIB0028|cit28',
'unstructured': 'An international randomised trial of additional treatments for COVID-19 '
'in hospitalised patients who are all receiving the local standard of '
'care www.clinicaltrialsregister.eu/ctr-search/trial/2020-001366-11/IT'},
{ 'key': '10.1002/14651858.CD014962-BIB0029|cit29',
'unstructured': 'An international randomised trial of additional treatments for COVID-19 '
'in hospitalised patients who are all receiving the local standard of '
'care www.clinicaltrialsregister.eu/ctr-search/trial/2020-001366-11/LT'},
{ 'key': '10.1002/14651858.CD014962-BIB0030|cit30',
'unstructured': 'An international randomised trial of additional treatments for COVID-19 '
'in hospitalised patients who are all receiving the local standard of '
'care - WHO-solidarity-Germany '
'www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001549-38-DE'},
{ 'key': '10.1002/14651858.CD014962-BIB0031|cit31',
'doi-asserted-by': 'crossref',
'unstructured': 'Harrington DP Baden LR Hogan JW A large, simple trial leading to complex '
'questions New England Journal of Medicine 2021 384 576 7 '
'10.1056/NEJMe2034294',
'DOI': '10.1056/NEJMe2034294'},
{ 'key': '10.1002/14651858.CD014962-BIB0032|cit32',
'doi-asserted-by': 'crossref',
'unstructured': 'Public health emergency solidarity trial of treatments for COVID-19 '
'infection in hospitalised patients www.isrctn.com/ISRCTN83971151 '
'https://doi.org/10.1186/ISRCTN83971151',
'DOI': '10.1186/ISRCTN83971151'},
{ 'issue': '6533',
'key': '10.1002/14651858.CD014962-BIB0033|cit33',
'doi-asserted-by': 'publisher',
'first-page': '972',
'DOI': '10.1126/science.371.6533.972',
'article-title': "WHO's treatment megatrial is at a standstill",
'volume': '371',
'author': 'Kupferschmidt',
'year': '2021',
'journal-title': 'Science'},
{ 'key': '10.1002/14651858.CD014962-BIB0034|cit34',
'unstructured': 'An international randomised trial of additional treatments for COVID-19 '
'in hospitalised patients who are all receiving the local standard of '
'care https://lbctr.moph.gov.lb/Trials/Details/4522'},
{ 'key': '10.1002/14651858.CD014962-BIB0035|cit35',
'unstructured': 'Trial of treatments for COVID-19 in hospitalised\xa0adults (discovery) '
'clinicaltrials.gov/ct2/show/NCT04315948'},
{ 'key': '10.1002/14651858.CD014962-BIB0036|cit36',
'unstructured': 'The efficacy of different anti-viral drugs in (severe acute respiratory '
'syndrome-corona virus-2) SARS-CoV-2 '
'clinicaltrials.gov/ct2/show/NCT04321616'},
{ 'key': '10.1002/14651858.CD014962-BIB0037|cit37',
'unstructured': 'Treatments for COVID-19: Canadian arm of the solidarity trial '
'clinicaltrials.gov/ct2/show/NCT04330690'},
{ 'key': '10.1002/14651858.CD014962-BIB0038|cit38',
'unstructured': 'An international randomised trial of additional treatments for COVID-19 '
'in hospitalised\xa0patients who are all receiving the local standard of '
'care - WHO-solidarity-Germany clinicaltrials.gov/ct2/show/NCT04575064'},
{ 'key': '10.1002/14651858.CD014962-BIB0039|cit39',
'unstructured': 'WHO COVID-19 solidarity trial for COVID-19 treatments '
'clinicaltrials.gov/ct2/show/NCT04647669'},
{ 'key': '10.1002/14651858.CD014962-BIB0040|cit40',
'doi-asserted-by': 'publisher',
'first-page': '2020.10.15.2020',
'DOI': '10.1101/2020.10.15.20209817',
'article-title': 'Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial '
'results',
'author': 'Pan',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1002/14651858.CD014962-BIB0041|cit41',
'doi-asserted-by': 'crossref',
'unstructured': 'Vanden Eynde JJ COVID-19: an update about the discovery clinical trial '
'Pharmaceuticals 2020 13 5 98 107 10.3390/ph13050098',
'DOI': '10.3390/ph13050098'},
{ 'issue': '8',
'key': '10.1002/14651858.CD014962-BIB0042|cit42',
'doi-asserted-by': 'publisher',
'first-page': '497',
'DOI': '10.1056/NEJMoa2023184',
'article-title': 'Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial '
'results',
'volume': '384',
'author': 'WHO Solidarity Trial Consortium',
'year': '2021',
'journal-title': 'New England Journal of Medicine'},
{ 'issue': '9',
'key': '10.1002/14651858.CD014962-BIB0043|cit43',
'doi-asserted-by': 'publisher',
'first-page': 'e041437',
'DOI': '10.1136/bmjopen-2020-041437',
'article-title': 'Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised '
'trial of the safety and efficacy of treatments for COVID-19 in '
'hospitalised adults',
'volume': '10',
'author': 'Ader',
'year': '2020',
'journal-title': 'BMJ Open'},
{ 'key': '10.1002/14651858.CD014962-BIB0044|cit44',
'doi-asserted-by': 'publisher',
'DOI': '10.1101/2021.01.08.20248149',
'article-title': 'Antiviral drugs in hospitalised patients with COVID-19 - the DisCoVeRy '
'trial',
'author': 'Ader',
'year': '2021',
'journal-title': 'Medrxiv'},
{ 'key': '10.1002/14651858.CD014962-BIB0045|cit45',
'doi-asserted-by': 'crossref',
'unstructured': 'Alpern JD Gertner E Off-label therapies for COVID-19 - are we all in '
'this together? Clinical Pharmacology & Therapeutics 108 2 182 4',
'DOI': '10.1002/cpt.1862'},
{ 'key': '10.1002/14651858.CD014962-BIB0046|cit46',
'article-title': 'Compassionate remdesivir treatment of severe COVID-19 pneumonia in '
'intensive care unit (ICU) and non-ICU patients: clinical outcome and\xa0'
'differences in post-treatment hospitalisation status',
'volume': '158',
'author': 'Rech',
'year': '2020',
'journal-title': 'Pharmacological Research'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0047|cit47',
'doi-asserted-by': 'crossref',
'first-page': '18',
'DOI': '10.3126/jbs.v7i1.29849',
'article-title': 'COVID-19: recent advances in epidemiology, virology, etiopathogenesis, '
'clinical trials and vaccine development',
'volume': '7',
'author': '\xa0Mohabeer',
'year': '2020',
'journal-title': 'Journal of Biomedical Sciences'},
{ 'key': '10.1002/14651858.CD014962-BIB0048|cit48',
'unstructured': 'Drug to prevent lung injury secondary to COVID 19 '
'www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50026'},
{ 'key': '10.1002/14651858.CD014962-BIB0049|cit49',
'unstructured': 'Remdesivir plus tocilizumab efficacy trial in moderate to severe '
'COVID-19 patients '
'www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49731'},
{ 'issue': '10',
'key': '10.1002/14651858.CD014962-BIB0050|cit50',
'article-title': 'Remdesivir and COVID-19',
'volume': '39',
'author': 'Deresinski',
'year': '2020',
'journal-title': 'Infectious Disease Alert'},
{ 'issue': '11',
'key': '10.1002/14651858.CD014962-BIB0051|cit51',
'article-title': 'Remdesivir\xa0injection',
'volume': '42',
'author': 'Elliott',
'year': '2020',
'journal-title': 'Internal Medicine Alert'},
{ 'key': '10.1002/14651858.CD014962-BIB0052|cit52',
'unstructured': 'Elliot W Chan J Remdesivir\xa0injection and baricitinib\xa0tablets '
'Internal Medicine Alert 2021'},
{ 'key': '10.1002/14651858.CD014962-BIB0053|cit53',
'unstructured': 'A phase 3 randomised study to evaluate the safety and antiviral activity '
'of remdesivir (GS-5734™) in participants with severe COVID-19 '
'www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/ES'},
{ 'key': '10.1002/14651858.CD014962-BIB0054|cit54',
'unstructured': 'Multi-centre, adaptive, randomised trial of the safety and efficacy of '
'treatments of COVID-19 in hospitalised adults - DisCoVeRy '
'www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23'},
{ 'key': '10.1002/14651858.CD014962-BIB0055|cit55',
'unstructured': 'A study to test a drug named remdesivir to evaluate the efficacy and '
'safety of the drug in treating patients with COVID-19 in an outpatient '
'setting (non-hospitalised) '
'www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-003510-12-DK'},
{ 'key': '10.1002/14651858.CD014962-BIB0056|cit56',
'unstructured': 'Clinical trial of remdesivir in COVID-19 patients'},
{ 'key': '10.1002/14651858.CD014962-BIB0057|cit57',
'doi-asserted-by': 'crossref',
'first-page': '917.e1',
'DOI': '10.1016/j.cmi.2021.02.029',
'article-title': 'A real-life setting evaluation of the effect of remdesivir on viral '
'load in COVID-19 patients admitted to a large tertiary centre in Israel',
'volume': '27',
'author': '\xa0Ben Zvi',
'year': '2021',
'journal-title': 'Clinical Microbiology and Infection'},
{ 'key': '10.1002/14651858.CD014962-BIB0058|cit58',
'doi-asserted-by': 'publisher',
'first-page': '1827',
'DOI': '10.1056/NEJMoa2015301',
'article-title': 'Remdesivir for 5 or 10 days in patients with severe COVID-19',
'volume': '383',
'author': 'Goldman',
'year': '2020',
'journal-title': 'New England Journal of Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0059|cit59',
'unstructured': 'Study to assess the safety and effectiveness of remdesivir in people '
'with severe COVID-19 www.isrctn.com/ISRCTN15874265'},
{ 'key': '10.1002/14651858.CD014962-BIB0060|cit60',
'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir '
'(GS-5734™) in participants with severe coronavirus disease (COVID-19) '
'clinicaltrials.gov/ct2/show/NCT04292899'},
{ 'key': '10.1002/14651858.CD014962-BIB0061|cit61',
'first-page': '279A',
'article-title': 'Impact of baseline alanine aminotransferase levels on the safety and '
'efficacy of remdesivir in severe COVID-19 patients',
'volume': '72',
'author': 'Goldman',
'year': '2020',
'journal-title': 'Hepatology'},
{ 'key': '10.1002/14651858.CD014962-BIB0062|cit62',
'unstructured': 'Study to assess the safety and effectiveness of remdesivir in people '
'with severe COVID-19 www.isrctn.com/ISRCTN15874265'},
{ 'key': '10.1002/14651858.CD014962-BIB0063|cit63',
'unstructured': 'Study to assess the safety and effectiveness of remdesivir in people '
'with moderate COVID-19 www.isrctn.com/ISRCTN85762140'},
{ 'issue': '4',
'key': '10.1002/14651858.CD014962-BIB0064|cit64',
'doi-asserted-by': 'crossref',
'first-page': '1581',
'DOI': '10.3390/ijms22041581',
'article-title': 'Comparison of antiviral activity of gemcitabine with '
'2′-gluoro-2′-deoxycytidine and combination therapy with remdesivir '
'against SARS-CoV-2',
'volume': '22',
'author': 'Jang',
'year': '2021',
'journal-title': 'International Journal of Molecular Sciences'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0065|cit65',
'article-title': 'Remdesivir\xa0injection and baricitinib\xa0tablets',
'volume': '43',
'author': 'Elliott',
'year': '2021',
'journal-title': 'Internal Medicine Alert'},
{ 'issue': '9',
'key': '10.1002/14651858.CD014962-BIB0066|cit66',
'doi-asserted-by': 'publisher',
'first-page': '795',
'DOI': '10.1056/NEJMoa2031994',
'article-title': 'Baricitinib plus remdesivir for hospitalized\xa0adults with COVID-19',
'volume': '384',
'author': 'Kalil',
'year': '2020',
'journal-title': 'New England Journal of Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0067|cit67',
'unstructured': 'Adaptive COVID-19 treatment trial 2 (ACTT-2) '
'clinicaltrials.gov/ct2/show/NCT04401579'},
{ 'issue': '11',
'key': '10.1002/14651858.CD014962-BIB0068|cit68',
'article-title': 'Remdesivir\xa0use in patients requiring mechanical ventilation due to '
'COVID-19',
'volume': '7',
'author': '\xa0Bernasconi',
'year': '2020',
'journal-title': 'Open Forum Infectious Diseases'},
{ 'key': '10.1002/14651858.CD014962-BIB0069|cit69',
'unstructured': 'An international randomised trial of additional treatments for COVID-19 '
'in hospitalised patients who are all receiving the local standard of '
'care https://lbctr.moph.gov.lb/Trials/Details/4522'},
{ 'key': '10.1002/14651858.CD014962-BIB0070|cit70',
'unstructured': 'Medical Brief Remdesivir for COVID-19 improves time to recovery - '
'peer-reviewed adaptive COVID-19 teatment trial '
'www.medicalbrief.co.za/archives/remdesivir-for-covid-19-improves-time-to-recovery-peer-reviewed-adaptive-covid-19-treatment-trial/ '
'2020 304'},
{ 'key': '10.1002/14651858.CD014962-BIB0071|cit71',
'unstructured': 'A trial of remdesivir in adults with mild and moderate COVID-19 '
'clinicaltrials.gov/ct2/show/NCT04252664'},
{ 'key': '10.1002/14651858.CD014962-BIB0072|cit72',
'unstructured': 'Efficacy of a self-test and self-alert mobile applet in detecting '
'susceptible infection of COVID-19 (COVID-19) '
'clinicaltrials.gov/ct2/show/NCT04256395'},
{ 'key': '10.1002/14651858.CD014962-BIB0073|cit73',
'unstructured': 'Adaptive COVID-19 treatment trial (ACTT) '
'clinicaltrials.gov/ct2/show/NCT04280705'},
{ 'key': '10.1002/14651858.CD014962-BIB0074|cit74',
'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir '
'(GS-5734™) in participants with severe coronavirus disease (COVID-19) '
'clinicaltrials.gov/ct2/show/NCT04292899'},
{ 'key': '10.1002/14651858.CD014962-BIB0075|cit75',
'unstructured': 'Expanded access remdesivir (RDV; GS-5734™) '
'clinicaltrials.gov/ct2/show/NCT04302766'},
{ 'key': '10.1002/14651858.CD014962-BIB0076|cit76',
'unstructured': 'Personalised\xa0health education against the health damage of novel '
'coronavirus (COVID-19) outbreak in Hungary (PROACTIVE-19) '
'clinicaltrials.gov/ct2/show/NCT04321928'},
{ 'key': '10.1002/14651858.CD014962-BIB0077|cit77',
'unstructured': 'Expanded access treatment protocol: temdesivir (RDV; GS-5734) for the '
'treatment of SARS-CoV2 (CoV) infection (COVID-19) '
'clinicaltrials.gov/ct2/show/NCT04323761'},
{ 'key': '10.1002/14651858.CD014962-BIB0078|cit78',
'unstructured': 'Stopping ACE-inhibitors in COVID-19 (ACEI-COVID) '
'clinicaltrials.gov/ct2/show/record/NCT04353596?view=record'},
{ 'key': '10.1002/14651858.CD014962-BIB0079|cit79',
'unstructured': 'Adaptive COVID-19 treatment trial 2 (ACTT-2) '
'clinicaltrials.gov/ct2/show/NCT04401579'},
{ 'key': '10.1002/14651858.CD014962-BIB0080|cit80',
'unstructured': 'A study to evaluate the efficacy and safety of remdesivir\xa0plus '
'tocilizumab\xa0compared with remdesivir\xa0plus placebo in '
'hospitalised\xa0participants with severe COVID-19 Pneumonia (REMDACTA) '
'clinicaltrials.gov/ct2/show/NCT04409262'},
{ 'key': '10.1002/14651858.CD014962-BIB0081|cit81',
'unstructured': 'Study of Merimepodib in combination with remdesivir in adult patients '
'with advanced COVID-19 clinicaltrials.gov/ct2/show/NCT04410354'},
{ 'key': '10.1002/14651858.CD014962-BIB0082|cit82',
'unstructured': 'Safety, tolerability and pharmacokinetics of inhaled nanoparticle '
'formulation of remdesivir (GS-5734) and NA-831 '
'clinicaltrials.gov/ct2/show/NCT04480333'},
{ 'key': '10.1002/14651858.CD014962-BIB0083|cit83',
'unstructured': 'I-SPY COVID-19 trial: an adaptive platform trial for critically ill '
'patients (I-SPY_COVID) clinicaltrials.gov/ct2/show/NCT04488081'},
{ 'key': '10.1002/14651858.CD014962-BIB0084|cit84',
'unstructured': 'Adaptive COVID-19 treatment trial 3 (ACTT-3) '
'clinicaltrials.gov/ct2/show/NCT04492475'},
{ 'key': '10.1002/14651858.CD014962-BIB0085|cit85',
'unstructured': 'Study to evaluate the efficacy and safety of remdesivir (GS-5734™) '
'treatment of coronavirus disease 2019 (COVID-19) in an outpatient '
'setting clinicaltrials.gov/ct2/show/NCT04501952'},
{ 'key': '10.1002/14651858.CD014962-BIB0086|cit86',
'unstructured': 'ACTIV-3: therapeutics for inpatients with COVID-19 (TICO) '
'clinicaltrials.gov/ct2/show/NCT04501978'},
{ 'key': '10.1002/14651858.CD014962-BIB0087|cit87',
'unstructured': 'Study in participants with early stage coronavirus disease 2019 '
'(COVID-19) to evaluate the safety, efficacy, and pharmacokinetics of '
'remdesivir\xa0administered by inhalation '
'clinicaltrials.gov/ct2/show/NCT04539262'},
{ 'key': '10.1002/14651858.CD014962-BIB0088|cit88',
'unstructured': 'ACTIV-5 / big effect trial (BET-A) for the treatment of COVID-19 '
'clinicaltrials.gov/ct2/show/NCT04583956'},
{ 'key': '10.1002/14651858.CD014962-BIB0089|cit89',
'unstructured': 'ACTIV-5 / big effect trial (BET-B) for the treatment of COVID-19 '
'clinicaltrials.gov/ct2/show/NCT04583969'},
{ 'key': '10.1002/14651858.CD014962-BIB0090|cit90',
'unstructured': 'Adaptive COVID-19 treatment trial 4 (ACTT-4) '
'clinicaltrials.gov/ct2/show/NCT04640168'},
{ 'key': '10.1002/14651858.CD014962-BIB0091|cit91',
'unstructured': 'IFN-beta 1b and remdesivir for COVID19 '
'clinicaltrials.gov/ct2/show/NCT04647695'},
{ 'key': '10.1002/14651858.CD014962-BIB0092|cit92',
'unstructured': 'Efficacy and safety of remdesivir and tociluzumab for the management of '
'severe COVID-19: a randomised controlled trial '
'clinicaltrials.gov/ct2/show/NCT04678739'},
{ 'key': '10.1002/14651858.CD014962-BIB0093|cit93',
'unstructured': 'Efficacy of remdisivir and Baricitinib for the treatment of severe COVID '
'19 patients clinicaltrials.gov/ct2/show/NCT04693026'},
{ 'key': '10.1002/14651858.CD014962-BIB0094|cit94',
'unstructured': 'Efficacy and safety of DWJ1248 with remdesivir in severe COVID-19 '
'patients clinicaltrials.gov/ct2/show/NCT04713176'},
{ 'key': '10.1002/14651858.CD014962-BIB0095|cit95',
'unstructured': 'Remdesivir in adults with COVID-19: Mansoura\xa0university hospital '
'experience clinicaltrials.gov/ct2/show/NCT04728880'},
{ 'key': '10.1002/14651858.CD014962-BIB0096|cit96',
'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir '
'(GS-5734™) in participants with severe coronavirus disease (COVID-19) '
'clinicaltrials.gov/ct2/show/NCT04292899'},
{ 'key': '10.1002/14651858.CD014962-BIB0097|cit97',
'doi-asserted-by': 'publisher',
'DOI': '10.1093/cid/ciaa1041',
'article-title': 'Remdesivir for severe coronavirus disease 2019 (COVID- 19) versus a '
'cohort receiving standard of care',
'volume': 'ciaa1041',
'author': '\xa0Perez',
'year': '2020',
'journal-title': 'Clinical Infectious Diseases'},
{ 'key': '10.1002/14651858.CD014962-BIB0098|cit98',
'doi-asserted-by': 'publisher',
'first-page': '497',
'DOI': '10.1101/2020.10.15.20209817',
'article-title': 'Repurposed antiviral drugs for COVID-19 -interim WHO SOLIDARITY trial '
'results',
'volume': '384',
'author': 'Pan',
'year': '2020',
'journal-title': 'medRxiv'},
{ 'key': '10.1002/14651858.CD014962-BIB0099|cit99',
'doi-asserted-by': 'publisher',
'first-page': '497',
'DOI': '10.1056/NEJMoa2023184',
'article-title': 'Repurposed antiviral drugs for COVID-19 - Interim WHO solidarity trial '
'results',
'volume': '384',
'author': 'Pan',
'year': '2021',
'journal-title': 'New England Journal of Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0100|cit100',
'doi-asserted-by': 'publisher',
'first-page': '62',
'DOI': '10.35772/ghm.2020.01106',
'article-title': 'Investigator initiated clinical trial of remdesivir for the treatment '
'of COVID-19 in Japan',
'volume': '3',
'author': 'Saito',
'year': '2021',
'journal-title': 'Global Health & Medicine'},
{ 'issue': '5',
'key': '10.1002/14651858.CD014962-BIB0101|cit101',
'doi-asserted-by': 'publisher',
'first-page': '1236',
'DOI': '10.1007/s43441-020-00159-7',
'article-title': 'Data monitoring for the Chinese clinical trials of remdesivir in '
'treating patients with COVID-19 during the pandemic crisis',
'volume': '54',
'year': '2020',
'journal-title': 'Therapeutic Innovation & Regulatory Science'},
{ 'key': '10.1002/14651858.CD014962-BIB0102|cit102',
'doi-asserted-by': 'publisher',
'first-page': '356',
'DOI': '10.17843/rpmesp.2020.372.5546',
'article-title': 'Rapid responses to the COVID-19 pandemic through science and global '
'collaboration: the solidarity clinical trial',
'volume': '37',
'author': 'Soto',
'year': '2020',
'journal-title': 'Revista Peruana de Medicina Experimental y Salud Pública'},
{ 'key': '10.1002/14651858.CD014962-BIB0103|cit103',
'doi-asserted-by': 'publisher',
'first-page': '1',
'DOI': '10.1208/s12248-020-00459-8',
'article-title': 'Remdesivir for treatment of COVID-19: combination of pulmonary and IV '
'administration may offer additional\xa0benefit',
'volume': '22',
'author': 'Sun',
'year': '2020',
'journal-title': 'AAPS Journal'},
{ 'issue': '13',
'key': '10.1002/14651858.CD014962-BIB0104|cit104',
'article-title': 'Early data on remdesivir for severe COVID-19: a promising start?',
'volume': '42',
'author': 'Tran',
'year': '2020',
'journal-title': 'Internal Medicine Alert'},
{ 'key': '10.1002/14651858.CD014962-BIB0105|cit105',
'unstructured': 'A trial of remdesivir in adults with mild and moderate COVID-19 '
'https://clinicaltrials.gov/ct2/show/NCT04252664'},
{ 'key': '10.1002/14651858.CD014962-BIB0106|cit106',
'unstructured': 'Antiviral activity and safety of remdesivir in Bangladeshi patients with '
'severe coronavirus disease (COVID-19) '
'https://clinicaltrials.gov/ct2/show/NCT04596839'},
{ 'key': '10.1002/14651858.CD014962-BIB0107|cit107',
'doi-asserted-by': 'publisher',
'first-page': '106272',
'DOI': '10.1016/j.cct.2021.106272',
'article-title': 'Remdesivir for the treatment of COVID-19: a systematic review and '
'meta-analysis of randomised controlled trials',
'volume': '101',
'author': 'Al-Abdouh',
'year': '2021',
'journal-title': 'Contemporary Clinical Trials'},
{ 'key': '10.1002/14651858.CD014962-BIB0108|cit108',
'doi-asserted-by': 'publisher',
'first-page': '606429',
'DOI': '10.3389/fmed.2020.606429',
'article-title': 'Mortality benefit of remdesivir in COVID-19: a systematic review and '
'meta-analysis',
'volume': '7',
'author': 'Bansal',
'year': '2021',
'journal-title': 'Frontiers in Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0109|cit109',
'unstructured': 'Bhimraj A Morgan RL Shumaker AH Lavergne V Baden L Cheng VC IDSA '
'guidelines on the treatment and management of patients with COVID-19 '
'www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management'},
{ 'issue': '9',
'key': '10.1002/14651858.CD014962-BIB0110|cit110',
'doi-asserted-by': 'publisher',
'first-page': 'e1003346',
'DOI': '10.1371/journal.pmed.1003346',
'article-title': 'Occurrence and transmission potential of asymptomatic and '
'presymptomatic SARS-CoV-2 infections: a living systematic review and '
'meta-analysis',
'volume': '17',
'author': 'Buitrago-Garcia',
'year': '2020',
'journal-title': 'PLoS Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0111|cit111',
'unstructured': 'Centers for Disease Control and Prevention COVIDView - a weekly '
'surveillance summary of U.S. COVID-19 activity (Key updates for week 43) '
'www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html'},
{ 'key': '10.1002/14651858.CD014962-BIB0112|cit112',
'unstructured': 'German COVID-19 evidence-ecosystem www.covid-evidenz.de'},
{ 'issue': '7',
'key': '10.1002/14651858.CD014962-BIB0113|cit113',
'doi-asserted-by': 'publisher',
'DOI': '10.1002/14651858.CD013600.pub3',
'article-title': 'Convalescent plasma or hyperimmune immunoglobulin for people with '
'COVID-19: a living systematic review',
'author': 'Chai',
'year': '2020',
'journal-title': 'Cochrane Database of Systematic Reviews'},
{ 'issue': '4',
'key': '10.1002/14651858.CD014962-BIB0114|cit114',
'doi-asserted-by': 'publisher',
'first-page': '418',
'DOI': '10.1002/jmv.25681',
'article-title': 'Emerging coronaviruses: genome structure, replication, and pathogenesis',
'volume': '92',
'author': 'Chen',
'year': '2020',
'journal-title': 'Journal of Medical Virology'},
{ 'key': '10.1002/14651858.CD014962-BIB0115|cit115',
'doi-asserted-by': 'publisher',
'first-page': 'm1091',
'DOI': '10.1136/bmj.m1091',
'article-title': 'Clinical characteristics of 113 deceased patients with coronavirus '
'disease 2019: retrospective study',
'volume': '368',
'author': 'Chen',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1002/14651858.CD014962-BIB0116|cit116',
'doi-asserted-by': 'publisher',
'first-page': '104786',
'DOI': '10.1016/j.antiviral.2020.104786',
'article-title': 'Remdesivir, lopinavir, emetine, and homoharringtonine inhibit '
'SARS-CoV-2 replication in vitro',
'volume': '178',
'author': 'Wong',
'year': '2020',
'journal-title': 'Antiviral Research'},
{ 'key': '10.1002/14651858.CD014962-BIB0117|cit117',
'unstructured': 'Guidance for the production and publication of Cochrane living '
'systematic reviews: Cochrane Reviews in living mode Available from '
'community.cochrane.org/review-production/production-resources/living-systematic-reviews'},
{ 'key': '10.1002/14651858.CD014962-BIB0118|cit118',
'unstructured': 'Core outcome set developers’ response to COVID-19 '
'www.comet-initiative.org/Studies/Details/1538'},
{ 'key': '10.1002/14651858.CD014962-BIB0119|cit119',
'unstructured': 'Veritas Health Innovation Covidence'},
{ 'key': '10.1002/14651858.CD014962-BIB0120|cit120',
'unstructured': 'Remdesivir for the treatment of hospitalized adults COVID-19 patients '
'(part of German Ecosystem CEO-sys) '
'www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021238065'},
{ 'key': '10.1002/14651858.CD014962-BIB0121|cit121',
'volume-title': 'Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins '
'JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). '
'Cochrane Handbook for Systematic Reviews of Interventions version 6.2 '
'(updated February 2021).\xa0Available from trai',
'author': 'Deeks',
'year': '2020'},
{ 'issue': '12',
'key': '10.1002/14651858.CD014962-BIB0122|cit122',
'doi-asserted-by': 'publisher',
'first-page': '6771',
'DOI': '10.1073/pnas.1922083117',
'article-title': 'Prophylactic and therapeutic remdesivir (GS5734) treatment in the '
'rhesus macaque model of MERS-CoV infection',
'volume': '117',
'author': 'Wit',
'year': '2020',
'journal-title': 'Proceedings of the National Academy of Sciences'},
{ 'key': '10.1002/14651858.CD014962-BIB0123|cit123',
'unstructured': 'Eldridge S Campbell M Campbell M Dahota A Giraudeau B Higgins JT Revised '
'Cochrane risk of bias tool for randomized trials (RoB 2.0). Additional '
'considerations for cluster-randomized trials '
'www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-cluster-randomized-trials'},
{ 'issue': '4',
'key': '10.1002/14651858.CD014962-BIB0124|cit124',
'doi-asserted-by': 'publisher',
'first-page': 'e2187',
'DOI': '10.1002/rmv.2187',
'article-title': 'Efficacy and safety of remdesivir in hospitalised COVID-19 patients: '
'systematic review and meta-analysis including network meta-analysis',
'volume': '31',
'author': 'Elsawah',
'year': '2021',
'journal-title': 'Reviews in Medical Virology'},
{ 'key': '10.1002/14651858.CD014962-BIB0125|cit125',
'unstructured': 'European Medicines Agency Summary on compassionate use remdesivir Gilead '
'www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf'},
{ 'key': '10.1002/14651858.CD014962-BIB0126|cit126',
'unstructured': 'European Commission authorises first treatment against COVID-19 '
'eeas.europa.eu/headquarters/headquarters-homepage/82135'},
{ 'key': '10.1002/14651858.CD014962-BIB0127|cit127',
'unstructured': 'Fact sheet for health care providers Emergency Use Authorisazation (EUA) '
'of remdesivir (GS-5734™) '
'www.askgileadmedical.com/downloads/pdfs/EUA%20Fact%20Sheet%20for%20HCPs.pdf'},
{ 'issue': '16',
'key': '10.1002/14651858.CD014962-BIB0128|cit128',
'doi-asserted-by': 'publisher',
'DOI': '10.2807/1560-7917.ES.2021.26.16.2100348',
'article-title': 'Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or '
'P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021',
'volume': '26',
'author': 'Funk',
'year': '2021',
'journal-title': 'Eurosurveillance'},
{ 'issue': '12',
'key': '10.1002/14651858.CD014962-BIB0129|cit129',
'doi-asserted-by': 'publisher',
'first-page': '1159',
'DOI': '10.1080/1744666X.2021.1847640',
'article-title': 'Natural history of COVID-19 and therapeutic options',
'volume': '16',
'author': 'Million',
'year': '2020',
'journal-title': 'Expert Review of Clinical Immunology'},
{ 'issue': '4',
'key': '10.1002/14651858.CD014962-BIB0130|cit130',
'doi-asserted-by': 'publisher',
'first-page': '794',
'DOI': '10.1016/j.cell.2020.06.040',
'article-title': 'Making sense of mutation: what D614G means for the COVID-19 pandemic '
'remains unclear',
'volume': '182',
'author': 'Rasmussen',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': '10.1002/14651858.CD014962-BIB0131|cit131',
'doi-asserted-by': 'publisher',
'first-page': '557',
'DOI': '10.1136/bmj.327.7414.557',
'article-title': 'Measuring inconsistency in metaanalyses',
'volume': '327',
'author': 'Higgins',
'year': '2003',
'journal-title': 'BMJ'},
{ 'key': '10.1002/14651858.CD014962-BIB0132|cit132',
'unstructured': 'Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA '
'Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 '
'(updated February 2021). Cochrane, 2021 Available from '
'training.cochrane.org/handbook'},
{ 'key': '10.1002/14651858.CD014962-BIB0133|cit133',
'unstructured': 'Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized '
'trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, '
'Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of '
'Interventions Version 6.2 (updated February 2021). Cochrane, 2021 '
'Available from training.cochrane.org/handbook'},
{ 'key': '10.1002/14651858.CD014962-BIB0134|cit134',
'unstructured': 'Higgins JP Savović J Page MJ Elbers RG Sterne JA Chapter 8: Assessing '
'risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler '
'J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for '
'Systematic Reviews of Interventions Version 6.2 (updated February 2021). '
'Cochrane, 2021 Available from training.cochrane.org/handbook'},
{ 'key': '10.1002/14651858.CD014962-BIB0135|cit135',
'unstructured': 'Higgins JP Tianging L Deeks JJ Chapter 6: Choosing effect measures and '
'computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, '
'Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for '
'Systematic Reviews of Interventions Version 6.2 (updated February 2021). '
'Cochrane, 2021 Available from training.cochrane.org/handbook'},
{ 'key': '10.1002/14651858.CD014962-BIB0136|cit136',
'doi-asserted-by': 'crossref',
'unstructured': 'Hsu CY Lai CC Yen AMF Chen SLS Chen HH Efficacy of remdesivir in '
'COVID-19 patients with a simulated two-arm controlled study (preprint) '
'medRxiv 2021 10.1101/2020.05.02.20088559',
'DOI': '10.1101/2020.05.02.20088559'},
{ 'key': '10.1002/14651858.CD014962-BIB0137|cit137',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s11427-020-1661-4',
'article-title': 'Clinical characteristics of 24 asymptomatic infections with COVID-19 '
'screened among close contacts in Nanjing, China',
'volume': '63',
'author': 'Hu',
'year': '2020',
'journal-title': 'Science China Life Sciences'},
{ 'issue': '10223',
'key': '10.1002/14651858.CD014962-BIB0138|cit138',
'doi-asserted-by': 'publisher',
'first-page': '497',
'DOI': '10.1016/S0140-6736(20)30183-5',
'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in '
'Wuhan, China',
'volume': '395',
'author': 'Huang',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1002/14651858.CD014962-BIB0139|cit139',
'doi-asserted-by': 'publisher',
'DOI': '10.7326/M20-8148',
'article-title': 'Major update: remdesivir for adults with COVID-19: a living systematic '
'review and meta-analysis for the American College of Physicians '
'Practice Points',
'volume': '2021',
'author': 'Kaka',
'year': '2021',
'journal-title': 'Annals of Internal Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0140|cit140',
'doi-asserted-by': 'crossref',
'first-page': '853',
'DOI': '10.1016/S2213-2600(20)30316-7',
'article-title': 'Case characteristics, resource use, and outcomes of 10 021 patients '
'with COVID-19 admitted to 920 German hospitals: an observational study',
'volume': '8',
'author': 'Karagiannidis',
'year': '2020',
'journal-title': 'Lancet Respiratory Medicine'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0141|cit141',
'doi-asserted-by': 'publisher',
'DOI': '10.1002/14651858.CD013825',
'article-title': 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19',
'author': 'Hirsch',
'year': '2021',
'journal-title': 'Cochrane Database of Systematic Reviews'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0142|cit142',
'doi-asserted-by': 'publisher',
'first-page': '13',
'DOI': '10.1007/s13337-020-00571-5',
'article-title': 'Structural, glycosylation and antigenic variation between 2019 novel '
'coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)',
'volume': '31',
'author': 'Kumar',
'year': '2020',
'journal-title': 'VirusDisease'},
{ 'key': '10.1002/14651858.CD014962-BIB0143|cit143',
'doi-asserted-by': 'publisher',
'DOI': '10.1093/jac/dkab093',
'article-title': 'Clinical efficacy and safety of remdesivir in patients with COVID-19: a '
'systematic review and network meta-analysis of randomised controlled '
'trials',
'author': 'Lai',
'year': '2021',
'journal-title': 'Journal of Antimicrobial Chemotherapy'},
{ 'issue': '9',
'key': '10.1002/14651858.CD014962-BIB0144|cit144',
'doi-asserted-by': 'publisher',
'first-page': '577-82',
'DOI': '10.7326/M20-0504',
'article-title': 'The incubation period of coronavirus disease 2019 (COVID-19) from '
'publicly reported confirmed cases: estimation and application',
'volume': '172',
'author': 'Lauer',
'year': '2020',
'journal-title': 'Annals of Internal Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0145|cit145',
'unstructured': 'Li T Higgins JP Deeks JJ Cochrane Handbook for Systematic Reviews of '
'Interventions Version 6.2.\xa0(updated February 2021). Cochrane, 2020. '
'Available from training.cochrane.org/handbook'},
{ 'issue': '2',
'key': '10.1002/14651858.CD014962-BIB0146|cit146',
'doi-asserted-by': 'publisher',
'first-page': '102',
'DOI': '10.1016/j.jpha.2020.03.001',
'article-title': 'Molecular immune pathogenesis and diagnosis of COVID-19',
'volume': '10',
'author': 'Li',
'year': '2020',
'journal-title': 'Journal of Pharmaceutical Analysis'},
{ 'issue': '3',
'key': '10.1002/14651858.CD014962-BIB0147|cit147',
'doi-asserted-by': 'publisher',
'first-page': '335',
'DOI': '10.1016/S1470-2045(20)30096-6',
'article-title': 'Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China',
'volume': '21',
'author': 'Liang',
'year': '2020',
'journal-title': 'Lancet Oncology'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0148|cit148',
'doi-asserted-by': 'publisher',
'first-page': '1',
'DOI': '10.1038/srep43395.',
'article-title': 'GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and '
'Paramyxoviruses',
'volume': '7',
'author': 'Lo',
'year': '2017',
'journal-title': 'Scientific Reports'},
{ 'issue': '11',
'key': '10.1002/14651858.CD014962-BIB0149|cit149',
'doi-asserted-by': 'publisher',
'first-page': '1203',
'DOI': '10.3390/v12111203',
'article-title': 'Viewpoint: origin of SARS-CoV-2',
'volume': '12',
'author': 'Lundstrom',
'year': '2020',
'journal-title': 'Viruses'},
{ 'key': '10.1002/14651858.CD014962-BIB0150|cit150',
'unstructured': 'Norwegian MAGIC Evidence Ecosystem Foundation\xa0(powered by UserVoice '
'Inc.) MAGICapp'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0151|cit151',
'doi-asserted-by': 'publisher',
'first-page': '499',
'DOI': '10.1002/jmv.26261',
'article-title': 'An update on the origin of SARS-CoV-2: despite closest identity, bat '
'(RaTG13) and pangolin derived coronaviruses varied in the critical '
'binding site and O-linked glycan residues',
'volume': '93',
'author': 'Malaiyan',
'year': '2020',
'journal-title': 'Journal of Medical Virology'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0152|cit152',
'doi-asserted-by': 'publisher',
'first-page': 'e00162',
'DOI': '10.1128/CMR.00162-20',
'article-title': 'Remdesivir against COVID-19 and other viral diseases',
'volume': '34',
'author': 'Malin',
'year': '2020',
'journal-title': 'Clinical Microbiology Reviews'},
{ 'issue': '24',
'key': '10.1002/14651858.CD014962-BIB0153|cit153',
'doi-asserted-by': 'publisher',
'first-page': '7215',
'DOI': '10.1021/jm060776w.',
'article-title': 'Application of phosphoramidate ProTide technology significantly '
'improves antiviral potency of carbocyclic adenosine derivatives',
'volume': '49',
'author': 'McGuigan',
'year': '2006',
'journal-title': 'Journal of Medicinal Chemistry'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0154|cit154',
'doi-asserted-by': 'publisher',
'first-page': 'e33',
'DOI': '10.1016/j.jinf.2020.04.004',
'article-title': 'CT imaging and clinical course of asymptomatic cases with COVID-19 '
'pneumonia at admission in Wuhan, China',
'volume': '81',
'author': 'Meng',
'year': '2020',
'journal-title': 'Journal of Infection'},
{ 'key': '10.1002/14651858.CD014962-BIB0155|cit155',
'unstructured': 'Mircosoft Excel Microsoft Corporation 2018'},
{ 'issue': '7',
'key': '10.1002/14651858.CD014962-BIB0156|cit156',
'doi-asserted-by': 'publisher',
'first-page': 'e1000097',
'DOI': '10.1371/journal.pmed.1000097',
'article-title': 'Preferred reporting items for systematic reviews and meta-analyses: the '
'PRISMA statement',
'volume': '6',
'author': 'Moher',
'year': '2009',
'journal-title': 'PLOS Medicine'},
{ 'issue': '24',
'key': '10.1002/14651858.CD014962-BIB0157|cit157',
'doi-asserted-by': 'publisher',
'first-page': '2293',
'DOI': '10.1056/NEJMoa1910993',
'article-title': 'A randomised, controlled trial of Ebola virus disease therapeutics',
'volume': '381',
'author': 'Mulangu',
'year': '2019',
'journal-title': 'New England Journal of Medicine'},
{ 'issue': '9',
'key': '10.1002/14651858.CD014962-BIB0158|cit158',
'doi-asserted-by': 'publisher',
'first-page': '925',
'DOI': '10.1099/jgv.0.001453',
'article-title': 'SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, '
'rapid adaptation and cytopathology',
'volume': '101',
'author': 'Dalebout',
'year': '2020',
'journal-title': 'Journal of General Virology'},
{ 'issue': '5',
'key': '10.1002/14651858.CD014962-BIB0159|cit159',
'doi-asserted-by': 'publisher',
'first-page': '362',
'DOI': '10.7326/M20-3012',
'article-title': 'Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review',
'volume': '173',
'author': 'Oran',
'year': '2020',
'journal-title': 'Annals of Internal Medicine'},
{ 'issue': '19',
'key': '10.1002/14651858.CD014962-BIB0160|cit160',
'doi-asserted-by': 'publisher',
'first-page': '1915',
'DOI': '10.1001/jama.2020.6130',
'article-title': 'Association of public health interventions with the epidemiology of the '
'COVID-19 outbreak in Wuhan, China',
'volume': '323',
'author': 'Pan',
'year': '2020',
'journal-title': 'JAMA'},
{ 'issue': '24',
'key': '10.1002/14651858.CD014962-BIB0161|cit161',
'doi-asserted-by': 'publisher',
'first-page': '2815',
'DOI': '10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8',
'article-title': 'Extracting summary statistics to perform metaanalyses of the published '
'literature for survival endpoints',
'volume': '17',
'author': 'Parmar',
'year': '1998',
'journal-title': 'Statistics in Medicine'},
{ 'key': '10.1002/14651858.CD014962-BIB0162|cit162',
'doi-asserted-by': 'publisher',
'first-page': 'm1966',
'DOI': '10.1136/bmj.m1966',
'article-title': 'Factors associated with hospital admission and critical illness among '
'5279 people with coronavirus disease 2019 in New York City: prospective '
'cohort study',
'volume': '369',
'author': 'Petrilli',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1002/14651858.CD014962-BIB0163|cit163',
'doi-asserted-by': 'publisher',
'DOI': '10.17605/OSF.IO/DWF53',
'article-title': 'Safety and effectiveness of convalescent plasma or\xa0hyperimmune '
'globulin for people with COVID-19: a rapid\xa0review',
'author': 'Piechotta',
'year': '2020',
'journal-title': 'OSF Registries'},
{ 'issue': '12',
'key': '10.1002/14651858.CD014962-BIB0164|cit164',
'doi-asserted-by': 'publisher',
'first-page': 'e0243705',
'DOI': '10.1371/journal.pone.0243705',
'article-title': 'Efficacy and harms of remdesivir for the treatment of COVID-19: a '
'systematic review and meta-analysis',
'volume': '15',
'author': 'Piscoya',
'year': '2020',
'journal-title': 'PLOS ONE'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0165|cit165',
'doi-asserted-by': 'publisher',
'first-page': '389',
'DOI': '10.25646/7111',
'article-title': 'A higher mortality rate and long ventilation times differentiate '
'COVID-19 from severe respiratory infections in flu waves',
'volume': '24',
'author': 'Potere',
'year': '2020',
'journal-title': 'Critical Care'},
{ 'key': '10.1002/14651858.CD014962-BIB0166|cit166',
'unstructured': 'The Cochrane Collaboration Review Manager Web (RevMan Web) 2021'},
{ 'issue': '20',
'key': '10.1002/14651858.CD014962-BIB0167|cit167',
'doi-asserted-by': 'publisher',
'first-page': '2052',
'DOI': '10.1001/jama.2020.6775',
'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 '
'patients hospitalized with COVID-19 in the New York City area',
'volume': '323',
'author': 'Richardson',
'year': '2020',
'journal-title': 'JAMA'},
{ 'issue': '5',
'key': '10.1002/14651858.CD014962-BIB0168|cit168',
'first-page': '376',
'article-title': 'The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a '
'systematic review',
'volume': '12',
'author': 'Roshanshad',
'year': '2020',
'journal-title': 'Iranian Journal of Microbiology'},
{ 'key': '10.1002/14651858.CD014962-BIB0169|cit169',
'doi-asserted-by': 'publisher',
'first-page': '126',
'DOI': '10.1016/j.jclinepi.2019.10.014',
'article-title': 'GRADE guidelines 26: informative statements to communicate the findings '
'of systematic reviews of interventions',
'volume': '119',
'author': 'Santesso',
'year': '2020',
'journal-title': 'Journal of Clinical Epidemiology'},
{ 'issue': 'S11',
'key': '10.1002/14651858.CD014962-BIB0170|cit170',
'doi-asserted-by': 'publisher',
'first-page': '2',
'DOI': '10.25646/7170',
'article-title': 'Disease severity of the first COVID-19 wave in Germany using reporting '
'data from the national notification system',
'volume': '5',
'author': 'Schilling',
'year': '2020',
'journal-title': 'Journal of Health Monitoring'},
{ 'key': '10.1002/14651858.CD014962-BIB0171|cit171',
'unstructured': 'Schünemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: '
'Completing ‘Summary of findings’ tables and grading the certainty of the '
'evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page '
'MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of '
'Interventions Version 6.2 (updated February 2021). Cochrane, 2021 '
'Available from training.cochrane.org/handbook'},
{ 'key': '10.1002/14651858.CD014962-BIB0172|cit172',
'doi-asserted-by': 'publisher',
'DOI': '10.3201/eid2708.211145',
'article-title': 'Delayed antibody and T-cell response to BNT162b2 vaccination in the '
'elderly, Germany',
'volume': '27 (early relea',
'author': 'Schwarz',
'journal-title': 'Emerging Infectious Diseases'},
{ 'issue': '396',
'key': '10.1002/14651858.CD014962-BIB0173|cit173',
'doi-asserted-by': 'publisher',
'first-page': 'eaal3653',
'DOI': '10.1126/scitranslmed.aal3653',
'article-title': 'Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic '
'coronaviruses',
'volume': '9',
'author': 'Sheahan',
'year': '2017',
'journal-title': 'Science Translational Medicine'},
{ 'issue': '1',
'key': '10.1002/14651858.CD014962-BIB0174|cit174',
'doi-asserted-by': 'publisher',
'first-page': '222',
'DOI': '10.1038/s41467-019-13940-6',
'article-title': 'Comparative therapeutic efficacy of remdesivir and combination '
'lopinavir, ritonavir and interferon beta against MERS-CoV',
'volume': '11',
'author': 'Sheahan',
'year': '2020',
'journal-title': 'Nature Communications'},
{ 'issue': '5',
'key': '10.1002/14651858.CD014962-BIB0175|cit175',
'doi-asserted-by': 'publisher',
'first-page': '1648',
'DOI': '10.1021/acs.jmedchem.6b01594',
'article-title': 'Discovery and synthesis of a phosphoramidate prodrug of a '
'pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the '
'treatment of ebola and emerging viruses',
'volume': '60',
'author': 'Siegel',
'year': '2017',
'journal-title': 'Journal of Medicinal Chemistry'},
{ 'key': '10.1002/14651858.CD014962-BIB0176|cit176',
'doi-asserted-by': 'publisher',
'first-page': 'm2980',
'DOI': '10.1136/bmj.m2980',
'article-title': 'Drug treatments for COVID-19: living systematic review and network '
'meta-analysis',
'volume': '370',
'author': 'Siemieniuk',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1002/14651858.CD014962-BIB0177|cit177',
'doi-asserted-by': 'publisher',
'first-page': '124',
'DOI': '10.1016/j.jclinepi.2019.10.015',
'article-title': 'GRADE guidelines 27: how to calculate absolute effects for '
'time-to-event outcomes in summary of findings tables and evidence '
'profiles',
'volume': '118',
'author': 'Skoetz',
'year': '2020',
'journal-title': 'Journal of Clinical Epidemiology'},
{ 'key': '10.1002/14651858.CD014962-BIB0178|cit178',
'doi-asserted-by': 'publisher',
'first-page': 'l4898',
'DOI': '10.1136/bmj.l4898',
'article-title': 'RoB 2: a revised tool for assessing risk of bias in randomised trials',
'volume': '366',
'author': 'Sterne',
'year': '2019',
'journal-title': 'BMJ'},
{ 'issue': '2',
'key': '10.1002/14651858.CD014962-BIB0179|cit179',
'doi-asserted-by': 'publisher',
'DOI': '10.1002/14651858.CD013665.pub2',
'article-title': 'Signs and symptoms to determine if a patient presenting in primary care '
'or hospital outpatient settings has COVID-19 disease',
'author': 'Struyf',
'year': '2021',
'journal-title': 'Cochrane Database of Systematic Reviews'},
{ 'issue': '4',
'key': '10.1002/14651858.CD014962-BIB0180|cit180',
'doi-asserted-by': 'publisher',
'first-page': '326',
'DOI': '10.3390/v11040326',
'article-title': 'Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by '
'remdesivir',
'volume': '11',
'author': 'Tchesnokov',
'year': '2019',
'journal-title': 'Viruses'},
{ 'key': '10.1002/14651858.CD014962-BIB0181|cit181',
'doi-asserted-by': 'crossref',
'first-page': '16',
'DOI': '10.1186/1745-6215-8-16',
'article-title': 'Practical methods for incorporating summary time-to-event data into '
'meta-analysis',
'volume': '8',
'author': 'Tierney',
'year': '2007',
'journal-title': 'Trials'},
{ 'key': '10.1002/14651858.CD014962-BIB0182|cit182',
'doi-asserted-by': 'publisher',
'first-page': '3',
'DOI': '10.25646/7111',
'article-title': 'Higher lethality and long duration of ventilation distinguish COVID-19 '
'from severe respiratory tract infections in influenza waves.',
'volume': '41',
'author': 'Tolksdorf',
'year': '2020',
'journal-title': 'Epidemiologisches Bulletin'},
{ 'key': '10.1002/14651858.CD014962-BIB0183|cit183',
'doi-asserted-by': 'publisher',
'first-page': '43',
'DOI': '10.1016/j.amsu.2020.12.051',
'article-title': 'Remdesivir therapy in patients with COVID-19: a systematic review and '
'meta-analysis of randomised controlled trials',
'volume': '62',
'author': 'Vegivinti',
'year': '2021',
'journal-title': 'Annals of Medicine and Surgery'},
{ 'issue': '3',
'key': '10.1002/14651858.CD014962-BIB0184|cit184',
'doi-asserted-by': 'publisher',
'first-page': '269',
'DOI': '10.1038/s41422-020-0282-0',
'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged '
'novel coronavirus (2019-nCoV) in vitro',
'volume': '30',
'author': 'Wang',
'year': '2020',
'journal-title': 'Cell Research'},
{ 'issue': '7594',
'key': '10.1002/14651858.CD014962-BIB0185|cit185',
'doi-asserted-by': 'publisher',
'first-page': '381',
'DOI': '10.1038/nature17180',
'article-title': 'Therapeutic efficacy of the small molecule GS-5734 against ebola virus '
'in rhesus monkeys',
'volume': '531',
'author': 'Warren',
'year': '2016',
'journal-title': 'Nature'},
{ 'key': '10.1002/14651858.CD014962-BIB0186|cit186',
'doi-asserted-by': 'publisher',
'first-page': '200384',
'DOI': '10.1183/16000617.0384-2020',
'article-title': 'Current evidence for COVID-19 therapies: a systematic literature review',
'volume': '30',
'author': 'Welte',
'year': '2021',
'journal-title': 'European Respiratory Review'},
{ 'key': '10.1002/14651858.CD014962-BIB0187|cit187',
'unstructured': 'World Health Organization Cumulative number of reported probable cases '
'of SARS www.who.int/csr/sars/country/2003_07_11/en'},
{ 'key': '10.1002/14651858.CD014962-BIB0188|cit188',
'unstructured': 'World Health Organization Middle East respiratory syndrome coronavirus '
'(MERSCoV) www.who.int/emergencies/mers-cov/en'},
{ 'key': '10.1002/14651858.CD014962-BIB0189|cit189',
'unstructured': "World Health Organization Timeline: WHO's COVID-19 response "
'www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline'},
{ 'key': '10.1002/14651858.CD014962-BIB0190|cit190',
'unstructured': 'World Health Organization Estimating mortality from COVID-19 - '
'scientific brief '
'www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1'},
{ 'key': '10.1002/14651858.CD014962-BIB0191|cit191',
'unstructured': 'World Health Organization Report of the WHO-China joint mission on '
'coronavirus disease 2019 (COVID-19) '
'www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report'},
{ 'issue': '8',
'key': '10.1002/14651858.CD014962-BIB0192|cit192',
'doi-asserted-by': 'publisher',
'first-page': 'e192',
'DOI': '10.1016/S1473-3099(20)30483-7',
'article-title': 'A minimal common outcome measure set for COVID-19 clinical research',
'volume': '20',
'author': 'WHO Working Group on the Clinical Characterisation and Management of COVID-19 '
'infection',
'year': '2020',
'journal-title': 'Lancet Infectious Diseases'},
{ 'key': '10.1002/14651858.CD014962-BIB0193|cit193',
'unstructured': 'World Health Organization SARS-CoV-2 mink-associated variant strain - '
'Denmark '
'www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en'},
{ 'key': '10.1002/14651858.CD014962-BIB0194|cit194',
'unstructured': 'World Health Organization Therapeutics and COVID-19: living guideline '
'www.who.int/publications/i/item/therapeutics-and-covid-19-living-guideline'},
{ 'key': '10.1002/14651858.CD014962-BIB0195|cit195',
'unstructured': 'World Health Organization WHO Coronavirus Disease (COVID-19) Dashboard '
'covid19.who.int'},
{ 'key': '10.1002/14651858.CD014962-BIB0196|cit196',
'unstructured': 'World Health Organization WHO Coronavirus (COVID-19) Dashboard '
'covid19.who.int/'},
{ 'key': '10.1002/14651858.CD014962-BIB0197|cit197',
'unstructured': 'World Health Organization Origins of the SARS-CoV-2 virus '
'www.who.int/health-topics/coronavirus/origins-of-the-virus'},
{ 'key': '10.1002/14651858.CD014962-BIB0198|cit198',
'unstructured': 'World Health Organization Weekly epidemiological update - 16 March 2021 '
'https://www.who.int/publications/m/item/weekly-epidemiological-update---16-march-2021'},
{ 'key': '10.1002/14651858.CD014962-BIB0199|cit199',
'doi-asserted-by': 'publisher',
'first-page': '430',
'DOI': '10.1038/s41586-020-2521-4',
'article-title': 'Factors associated with COVID-19-related death using OpenSAFELY',
'volume': '584',
'author': 'Williamson',
'year': '2020',
'journal-title': 'Nature'},
{ 'key': '10.1002/14651858.CD014962-BIB0200|cit200',
'doi-asserted-by': 'publisher',
'first-page': '7824',
'DOI': '10.1038/s41586-020-2423-5',
'article-title': 'Clinical benefit of remdesivir in rhesus macaques infected with '
'SARS-CoV-2',
'volume': '585',
'author': 'Williamson',
'year': '2020',
'journal-title': 'Nature'},
{ 'issue': '2',
'key': '10.1002/14651858.CD014962-BIB0201|cit201',
'doi-asserted-by': 'publisher',
'first-page': '209',
'DOI': '10.7326/M20-5752',
'article-title': 'Remdesivir for adults with COVID-19: a living systematic review for an '
'American College of Physicians Practice Point',
'volume': '174',
'author': 'Wilt',
'year': '2021',
'journal-title': 'Annals of Internal Medicine'},
{ 'issue': '13',
'key': '10.1002/14651858.CD014962-BIB0202|cit202',
'doi-asserted-by': 'publisher',
'first-page': '1239',
'DOI': '10.1001/jama.2020.2648',
'article-title': 'Characteristics of and important lessons from the coronavirus disease '
'2019 (COVID-19) outbreak in China: summary of a report of 72314 cases '
'from the Chinese Center for Disease Control and Prevention',
'volume': '323',
'author': 'Wu',
'year': '2020',
'journal-title': 'JAMA'},
{ 'issue': '6485',
'key': '10.1002/14651858.CD014962-BIB0203|cit203',
'doi-asserted-by': 'publisher',
'first-page': '1444',
'DOI': '10.1126/science.abb2762',
'article-title': 'Structural basis for the recognition of SARS-CoV-2 by full-length human '
'ACE2',
'volume': '367',
'author': 'Yan',
'year': '2020',
'journal-title': 'Science'},
{ 'key': '10.1002/14651858.CD014962-BIB0204|cit204',
'doi-asserted-by': 'publisher',
'first-page': '198137',
'DOI': '10.1016/j.virusres.2020.198137',
'article-title': 'Effect of remdesivir on patients with COVID-19: a network meta-analysis '
'of randomised control trials',
'volume': '288',
'author': 'Yokoyama',
'year': '2020',
'journal-title': 'Virus Research'}],
'container-title': 'Cochrane Database of Systematic Reviews',
'original-title': [],
'language': 'en',
'deposited': { 'date-parts': [[2022, 5, 30]],
'date-time': '2022-05-30T09:41:37Z',
'timestamp': 1653903697000},
'score': 1,
'resource': {'primary': {'URL': 'http://doi.wiley.com/10.1002/14651858.CD014962'}},
'subtitle': [],
'editor': [{'name': 'Cochrane Haematology Group', 'sequence': 'first', 'affiliation': []}],
'short-title': [],
'issued': {'date-parts': [[2021, 8, 5]]},
'references-count': 204,
'journal-issue': {'issue': '8', 'published-online': {'date-parts': [[2021, 8]]}},
'URL': 'http://dx.doi.org/10.1002/14651858.CD014962',
'relation': {},
'ISSN': ['1465-1858'],
'subject': [],
'published': {'date-parts': [[2021, 8, 5]]}}
